Jacobi Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jacobi Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-600	Closed	-$9K	–	1407
2021 Q3	$9K	Hold	600	–	–	﹤0.01%	1087
2021 Q2	$12K	Hold	600	–	–	﹤0.01%	989
2021 Q1	$14K	Hold	600	–	–	﹤0.01%	889
2020 Q4	$15K	Sell	600 -600	-50%	-$19.9K	﹤0.01%	792
2020 Q3	$50K	Hold	1,200	–	–	0.01%	507
2020 Q2	$57K	Hold	1,200	–	–	0.01%	451
2020 Q1	$76K	Sell	1,200 -1,000	-45%	-$89.9K	0.02%	362
2019 Q4	$273K	Sell	2,200 -1,000	-31%	-$89.5K	0.05%	251
2019 Q3	$212K	Hold	3,200	–	–	0.04%	270
2019 Q2	$255K	Buy	+3,200	New	+$286K	0.05%	251

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jacobi Capital Management's ICPT Position: Q4 2021 in Review

Jacobi Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 600 shares — an estimated $9K sold.

Jacobi Capital Management first reported a position in ICPT in Q2 2019 and held it in 10 quarters. The position peaked at $273K in Q4 2019. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

Jacobi Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 600 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $9K.
Jacobi Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2019 and held it in 10 quarters.
Jacobi Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $273K in Q4 2019.
147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.